Harvard Bioscience Inc (HBIO)
2.29
+0.12
(+5.53%)
USD |
NASDAQ |
Nov 14, 16:00
2.295
0.00 (0.00%)
Pre-Market: 20:00
Harvard Bioscience Cash from Financing (Quarterly): 2.104M for Sept. 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 2.104M |
| June 30, 2024 | 0.177M |
| March 31, 2024 | -1.055M |
| December 31, 2023 | -4.116M |
| September 30, 2023 | -2.75M |
| June 30, 2023 | -2.375M |
| March 31, 2023 | -2.893M |
| December 31, 2022 | -2.73M |
| September 30, 2022 | 0.377M |
| June 30, 2022 | -0.578M |
| March 31, 2022 | 0.094M |
| December 31, 2021 | 2.594M |
| September 30, 2021 | 0.487M |
| June 30, 2021 | -0.192M |
| March 31, 2021 | -3.141M |
| December 31, 2020 | 3.357M |
| September 30, 2020 | -0.953M |
| June 30, 2020 | -5.30M |
| March 31, 2020 | -5.071M |
| December 31, 2019 | -0.429M |
| September 30, 2019 | -0.658M |
| June 30, 2019 | -1.533M |
| March 31, 2019 | -5.004M |
| December 31, 2018 | -0.354M |
| September 30, 2018 | 2.702M |
| Date | Value |
|---|---|
| June 30, 2018 | -0.539M |
| March 31, 2018 | 51.24M |
| December 31, 2017 | -0.439M |
| September 30, 2017 | -0.724M |
| June 30, 2017 | -0.361M |
| March 31, 2017 | -0.268M |
| December 31, 2016 | -1.21M |
| September 30, 2016 | -1.024M |
| June 30, 2016 | -0.908M |
| March 31, 2016 | -1.726M |
| December 31, 2015 | -1.161M |
| September 30, 2015 | -0.411M |
| June 30, 2015 | 0.20M |
| March 31, 2015 | 0.832M |
| December 31, 2014 | -1.099M |
| September 30, 2014 | 1.364M |
| June 30, 2014 | -0.568M |
| March 31, 2014 | -0.931M |
| December 31, 2013 | -12.48M |
| September 30, 2013 | -0.751M |
| June 30, 2013 | 9.696M |
| March 31, 2013 | 3.602M |
| December 31, 2012 | -0.524M |
| September 30, 2012 | -0.74M |
| June 30, 2012 | -0.566M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-5.30M
Minimum
Jun 2020
3.357M
Maximum
Dec 2020
-1.120M
Average
-0.7655M
Median
Cash from Financing (Quarterly) Benchmarks
| Bruker Corp | -2.70M |
| Azenta Inc | -224.44M |
| Bionano Genomics Inc | -1.978M |
| Akoya Biosciences Inc | -2.125M |
| Singular Genomics Systems Inc | 0.08M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -0.842M |
| Cash from Investing (Quarterly) | -1.111M |
| Free Cash Flow | 0.16M |
| Free Cash Flow Per Share (Quarterly) | -0.0448 |
| Free Cash Flow to Equity (Quarterly) | -4.131M |
| Free Cash Flow to Firm (Quarterly) | -1.038M |
| Free Cash Flow Yield | 0.16% |